Abstract
The allele frequencies of three restriction fragment length polymorphisms at the oestrogen receptor (ESR) locus were compared between breast cancer patients and controls. Leucocyte or tumour DMA from 238 and 122 patients, respectively, and leucocyte DNA from 672 controls was analysed. Alleles having the XbaI restriction site detected by the M72 probe (covering exon 2 and flanking introns) were significantly more frequent in patients than in controls (P = 0.033). Within the breast cancer population, the presence of the XbaI restriction site was associated with late onset of the disease but this association was only of borderline significance. The allele frequencies of the BstUI polymorphism in exon 1 and the PvuII polymorphism in intron 1 did not differ between cases and controls. However, alleles with the PvuII restriction site were more frequent in patients with progesterone receptor negative primary tumours than in patients with progesterone receptor positive primary tumours (P = 0.027). There was no significant association between any of the ESR polymorphisms and the oestrogen receptor status of the primary tumours. The results indicate that the ESR gene or a gene closely linked to it is involved in the development of at least a subset of breast carcinomas.
Similar content being viewed by others
References
Beahrs OH, Henson DE, Hutter RVP, Myers MH (1988) Manual for staging of cancer, 3rd edn. Lippincott, Philadelphia, p 145
Bodmer WF (1984) HLA system. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing. Springer, Berlin Heidelberg New York, pp 11–22
Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans GR, Thompson E, Mann JR, Martin J, Mitchell ELD, Santibanez-Kortef MF (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298–1304
Børresen A-L, Anderson TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen, Hovig E, Malkin D, Friend SH (1992) Screening for germ-line TP53 mutations in breast cancer patients. Cancer Res 52: 3234–3236
Castagnoli A, Maestri I, Bernardi F, Del Senno L (1987) PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15: 866
Clerget Darpoux F, Bonaïti-Pellié C (1992) Strategies based on marker information for the study of human disease. Ann Hum Genet 56: 147–155
Devilee P, Voesten A, Van Vliet M, Kuipers-Dijkshoorn N, Trent JM, Cornelisse CJ (1991) The common region for loss of heterozygosity on chromosome 6q in a series of breast tumours maps between the markers D6S37 and SOD2. Cytogenet Cell Genet 58: 1909
Easton DF, Bishop DT, Ford D, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer — results from 214 families. Am J Hum Genet 52: 678–701
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13
Garcia T, Lehrer S, Bloomer WD, Schachter B (1988) A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol 2: 785–791
Green S, Chambon P (1987) Oestradiol induction of a glucocorticoid-responsive gene by a chimeric receptor. Nature 325: 75–78
Greenberg DA (1993) Linkage analysis of “necessary” disease loci versus “susceptibility” loci. Am J Hum Genet 52: 135–143
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689
Hall JM, Friedman L, Guenther C, Lee MK, Weber JM, Black DM, King M-C (1992) Closing in on the breast cancer gene on chromosome 17q. Am J Hum Genet 50: 1235–1242
Hill SM, Fuqua SAW, Chamness GC, Greene GL, McGuire WL (1989) Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment polymorphism. Cancer Res 49: 145–148
Kumar V, Green S, Staub A, Chambon P (1986) Localization of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 5: 2231–2236
Kunkel LM, Smith, KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74: 1245–1249
Lehrer S, Sanchez M, Song HK, Dalton J, Levine E, Savoretti P, Thung SN, Schachter B (1990) Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet 335: 622–624
Lehrer S, Levine E, Savoretti P, Cropley J, Thung SN, Song HK, Mandell L, Shank B (1992) Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 339: 1108–1109
Li FP, Fraumeni Jr JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358–5362
Lobaccaro J-M, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Heron J-F, Pujol H, Sultan C (1993) Male breast cancer and the androgen receptor gene. Nature Genet 5: 109–110
Lynch HT, Albano WA, Danes S, Layton MA, Kimberling WJ, Lynch JF, Cheng SC, Costello KA, Mulcahy GM, Wagner CA, Tindall SL (1984) Genetic predisposition to breast cancer. Cancer 53: 612–622
Lynch HT, Watson P, Conway T, Fitzsimmons SL, Lynch J (1988) Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 11: 263–267
Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238
May FEB, Johnson MD, Wisseman LR, Wakeling AE, Kasatner P, Westley BR (1989) Regulation of progesterone receptor mRNA by oestradiol and antioestrogen in breast cancer cell lines. J Steroid Biochem 33: 1035–1041
Menasce LP, White GRM, Harrison CJ, Boyle JM (1993) Localization of the estrogen receptor locus (ESR) to chromosome 6q25. 1 by FISH and a simple post-FISH banding technique. Genomics 17: 263–265
Narod S, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir G (1991) Familial breast-ovarian cancer locus on chromosome 17ql2-q23. Lancet 338: 82–83
Parl FF, Cavener DR, Dupont WD (1989) Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res Treat 14: 57–64
Ponglikitmongkol M, Green S, Chambon P (1988) Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3385–3388
Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM, Evans HJ (1992) Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer 65: 527–528
Schmutzler RK, Sanchez M, Lehrer S, Chaparro CA, Phillips C, Rabin J, Sehachter B (1991) Incidence of an estrogen receptor polymorphism in breast cancer patients. Breast Cancer Res Treat 19: 111–117
Sideransky D, Tokino T, Helzisouer K, Rausch G, Zehnbauer B, Shelton B, Prestiglacomo L, Vogelstein B, Davidson N (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52: 2984–2986
Schachter B, Harlap S, Chaparro A, Rabin J, Lehrer S (1994) Estrogen receptor gene variant, spontaneous abortion and breast cancer risk. Proc Am Assoc Cancer Res 35: 290
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517
Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH (1990) Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348: 747–749
Taylor JA, Li Y, You M, Wilcox AJ, Liu E (1992) B region variant of the estrogen receptor gene. Nucleic Acids Res 20: 2895
Vollenweider-Zerargui L, Barrelet L, Wong Y, Lemarchand-Béraud T, Gómez F (1986) The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Cancer 57: 1171–1180
Winstanley J, Cooke T, George WD, Murray G, Holt S, Cronton R, Griffiths K, Nicholson R (1991) The long term prognostic signficance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 64: 99–101
Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ, Stratton MR (1992) A germeline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 2: 132–134
Yaich L, Dupont WD, Cavener DR, Parl FF (1992) Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 52: 77–83
Zuppan PJ, Hall JM, Ponglikitmongkol M, Spielman R, King M-C (1989) Polymorphisms at the estrogen receptor (ESR) locus and linkage relationships on chromosome 6q. Cytogenet Cell Genet 51: 1116
Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King M-C (1991) Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 48: 1065–1068
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anderson, T.I., Heimdal, K.R., Skrede, M. et al. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 94, 665–670 (1994). https://doi.org/10.1007/BF00206961
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00206961